The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
<h4>Background</h4>Bisphosphonate drugs can be used to improve the outcomes of women with breast cancer. Whilst many meta-analyses have quantified their potential benefits for patients, attempts at comprehensive quantification of potential adverse effects have been limited. We undertook...
Main Authors: | Christopher Jackson, Alexandra L J Freeman, Zśofia Szlamka, David J Spiegelhalter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246441 |
Similar Items
-
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
by: Christopher Jackson, et al.
Published: (2022-01-01) -
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis
by: Christopher Jackson, et al.
Published: (2022-01-01) -
The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis
by: Yan-Li Yang, et al.
Published: (2019-06-01) -
Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis.
by: Irit Ben-Aharon, et al.
Published: (2013-01-01) -
Bisphosphonates and primary breast cancer risk: an updated systematic review and meta-analysis involving 963,995 women
by: Liu Y, et al.
Published: (2019-07-01)